![Marcello Damiani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marcello Damiani
Hoofd Techniek/Wetenschap/O&O bij
BEIGENE LTD
Profiel
Mr. Marcello Damiani is a Chief Technology Officer at BeOne Medicines Ltd. and a Chief Digital & Operational Excellence Officer at ModernaTX, Inc. He is on the Board of Directors at Cellarity Inc. Mr. Damiani was previously employed as a Senior Partner by Flagship Pioneering, Inc., an Independent Non-Executive Director by BenevolentAI SA, a Chief Digital & Operational Excellence Officer by Moderna, Inc., and a Chief Information Officer & Senior Vice President by bioMérieux SA. He received his undergraduate degree from the Institut d'Administration Des Entreprises De Toulouse, a graduate degree from the Institut d'Administration Des Entreprises De Toulouse and an MBA from Trium Global Emba.
Actieve functies van Marcello Damiani
| Bedrijven | Functie | Begin |
|---|---|---|
| BEIGENE LTD | Hoofd Techniek/Wetenschap/O&O | 01-05-2025 |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Corporate Officer/Principal | - |
Cellarity Inc.
 Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Directeur/Bestuurslid | 01-01-2019 |
Eerdere bekende functies van Marcello Damiani
| Bedrijven | Functie | Einde |
|---|---|---|
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01-05-2025 |
| BENEVOLENTAI S.A. | Directeur/Bestuurslid | 02-05-2024 |
| MODERNA, INC. | Corporate Officer/Principal | 01-01-2022 |
| BIOMÉRIEUX | Hoofd Techniek/Wetenschap/O&O | 01-01-2015 |
Opleiding van Marcello Damiani
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
34
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
bioMérieux SA
 bioMérieux SA Medical SpecialtiesHealth Technology Develops biotechnological products specializing in in-vitro diagnostics and infectious diseases | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
Institut d'Administration Des Entreprises De Toulouse
 Institut d'Administration Des Entreprises De Toulouse Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trium Global Emba
 Trium Global Emba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
BenevolentAI SA
 BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery | Technology Services |
